Publications
31
Citations
899
Est. group size
—
Recurring co-author estimate
Active years
13
Publishing since 2014
Sarah Heintzman's work focuses on neuromuscular disorders, including spinal muscular atrophy, amyotrophic lateral sclerosis (ALS, a disease affecting nerve cells that control muscle movement), and related conditions like muscle and nerve diseases. Her research includes clinical treatment studies as well as practical aspects of running clinical trials at research sites. This work is largely clinical and translational, aimed at improving diagnosis and treatment for patients with these conditions.
Publication activity began around 2020 and has continued at a fairly steady pace since, with some year-to-year variation but no clear long-term increase or decrease.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Assessment of safety and efficacy of risdiplam treatment in adults with spinal muscular atrophy
Frontiers in Neurology · 2026
- Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the <scp>US</scp>
Muscle & Nerve · 2025
- Two Cases of POEMS Syndrome with Negative Skeletal X-rays Leading to Delayed Diagnosis and Ineffective Treatment (4137)
Neurology · 2021
- Neurology×8
- The Lancet Neurology×3
- Frontiers in Neurology×3
- JAMA×2
- Muscle & Nerve×2
- Stephen J. Kolb
Medicine · The Ohio State University
- Kelly Rich
Medicine · The Ohio State University
- Kathrin Meyer
Medicine · The Ohio State University
- Sara K. Custer
Medicine · Indiana University
- Amy Bartlett
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile